Multiple linear regression modeling of furosemide renal clearance and urinary excretion rate.
Multiple linear regression techniques were utilized to determine models for the renal clearance and urinary excretion rate of furosemide. Models for the renal clearance were formulated based on data collected from the literature. The best model predicted that the weight-normalized renal clearance was a function of the weight-normalized creatinine clearance, with coefficient values dependent on the presence or absence of heart, liver, and/or kidney failure. The predictive performance of this model was evaluated using a separate verification data set, and, prospectively, for a group of cardiac patients. The urinary excretion rate of furosemide is the primary determinate of response. Models for the furosemide excretion rate were formulated from data collected prospectively from a group of patients with cardiac disease. The best model predicted that the dose-normalized morning urinary excretion rate was a function of the blood urea nitrogen concentration (BUN), with modifications for the presence of liver failure and/or decompensated heart failure. The oral dosage required to produce a clinically optimal furosemide excretion rate in cardiac patients without liver disease was dose (mg) = 42.1/(0.925-0.0151 BUN).
Ponto
L L
LL
Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City 52242.
Schoenwald
R D
RD
D000368:Aged; D005260:Female; D005665:Furosemide / Q000493:pharmacokinetics* / Q000652:urine; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D016014:Linear Models; D008297:Male; D008657:Metabolic Clearance Rate / Q000502:physiology; D008875:Middle Aged; D008954:Models, Biological; D011446:Prospective Studies; D012189:Retrospective Studies
D005665:Furosemide